214 results on '"Westenberg, Herman G. M."'
Search Results
2. The influence of amphetamine on language activation: an fMRI study
3. Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine
4. Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats
5. Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade
6. An evaluation of the effect of NAS-181, a new selective 5-HT1B receptor antagonist, on extracellular 5-HT levels in rat frontal cortex
7. Impaired Neuroendocrine and Immune Response to Acute Stress in Medication-Naive Patients With a First Episode of Psychosis
8. Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo
9. NEUROPSYCHOLOGICAL PERFORMANCE IS RELATED TO CURRENT SOCIAL AND OCCUPATIONAL FUNCTIONING IN VETERANS WITH POSTTRAUMATIC STRESS DISORDER
10. The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients
11. Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks
12. MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients A preliminary report: A preliminary report
13. Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder
14. Attention and cognition in patients with obsessive–compulsive disorder
15. Altered Pain Processing in Veterans With Posttraumatic Stress Disorder
16. Recent developments in the psychopharmacology of social phobia
17. Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine
18. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients
19. MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine: A double blind placebo controlled study
20. Serotonergic function and late luteal phase dysphoric disorder
21. Flesinoxan Dose-Dependently Reduces Extracellular 5-Hydroxytryptamine (5-HT) in Rat Median Raphe and Dorsal Hippocampus Through Activation of 5-HT1A Receptors
22. Fluvoxamine in the treatment of menstrually related mood disorders
23. Partitioning the heritability of Tourette Syndrome and obsessive compulsive disorder reveals differences in genetic architecture
24. Abstracts of papers
25. Serotonin function in panic disorder: effect of 1–5-hydroxytryptophan in patients and controls
26. Clinical and Biochemical Effects of Selective Serotonin-Uptake Inhibitors in Anxiety Disorders
27. Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture
28. Catechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder
29. Deep Brain Stimulation Reveals a Dissociation of Consummatory and Motivated Behaviour in the Medial and Lateral Nucleus Accumbens Shell of the Rat
30. Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder
31. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude
32. Recent Advances in Understanding and Treating Social Anxiety Disorder
33. Prediction of Response to Paroxetine and Venlafaxine by Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized, Double-Blind Trial
34. Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats
35. Reduced sensitivity in the recognition of anger and disgust in social anxiety disorder
36. The influence of amphetamine on language activation: an fMRI study
37. Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740
38. Behavior Therapy Augments Response of Patients With Obsessive-Compulsive Disorder Responding to Drug Treatment
39. Changes in benzodiazepine receptor binding in Dutch veterans with posttraumatic stress disorder assessed with [C-11]-flumazenil and PET
40. Efficacy of Quetiapine in Generalized Social Anxiety Disorder
41. Bupropion for Patients With Obsessive-Compulsive Disorder
42. A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors
43. A Double-Blind Placebo-Controlled Study of Controlled Release Fluvoxamine for the Treatment of Generalized Social Anxiety Disorder
44. A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder
45. Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial
46. Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats
47. Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive–compulsive disorder: possible mechanisms and implications for clinical care
48. Effect of Olanzapine on Glutamate Levels in Cerebrospinal Fluid of Patients With Schizophrenia
49. Consensus Statement
50. Clinical Effects of Buspirone in Social Phobia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.